Evidence map›Paper›PMID 17628808›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2007

Sarcomas in children with neurofibromatosis type 1-poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution.

Ewa Bien, Teresa Stachowicz-Stencel, Danuta Sierota, Katarzyna Polczynska, Anna Szolkiewicz, Joanna Stefanowicz, Elzbieta Adamkiewicz-Drozynska, Piotr Czauderna, Wojciech Kosiak, Miroslawa Dubaniewicz-Wybieralska and 2 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ewa BienDepartment of Paediatrics, Haematology, Oncology and Endocrinology, Medical University, 7 Debinki Street, 80-211 Gdansk, Poland. ebien@amg.gda.pl
Teresa Stachowicz-Stencel
Danuta Sierota
Katarzyna Polczynska
Anna Szolkiewicz
Joanna Stefanowicz
Elzbieta Adamkiewicz-Drozynska
Piotr Czauderna
Wojciech Kosiak
Miroslawa Dubaniewicz-Wybieralska
Ewa Izycka-Swieszewska
Anna Balcerska
Gdańsk Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectsPatients with neurofibromatosis type 1 (NF1) are predisposed to developing soft tissue sarcomas (STS). MATERIALS AND

methodsWe report on four cases of STS diagnosed in locally advanced, unresectable stages in children with NF1 (three girls, one boy; age = 8 months-14 years). All patients received protocols for STS: Cooperative Weichteilsarkomstudie 91, 96 and 2002. One patient with limb rhabdomyosarcoma entered complete remission but developed late metastatic relapse and died of progression despite complete excision and autologous bone marrow transplantation. The other patient with bladder rhabdomyosarcoma died of neutropenia-related sepsis without remission. Patients with malignant peripheral nerve sheet tumour and malignant triton tumour located in the pelvis did not respond to therapy. One of them died of disease progression, while the other is disease-free 6 years post-therapy after mutilating tumour resection.

conclusionSTS in NF1 seem to display poor prognosis in spite of combined therapy; thus, children with NF1 should remain under detailed control of the oncologist.

Indexed as

Antineoplastic AgentsBone Marrow TransplantationChild, PreschoolCombined Modality TherapyDisease ProgressionFatal OutcomeFemaleHumansInfantMaleMuscle NeoplasmsNeoplasm MetastasisNeurofibromatosis 1PrognosisRadiotherapyRetroperitoneal NeoplasmsAntineoplastic Agents

Identifiers

PMID17628808
OpenAlexW1999885412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.